Assessing for the dysfunction of Lamp5 and related modulators of cortical inhibitory interneuronal function, with a view to unlocking the initial pathogenic event in ALS, may further inform pathophysiological insights into neurological disease and lead to development of novel therapeutic strategies. This evidence concerns the gene LAMP5 and nervous system disorder.